Tandem achieves cybersecurity certification milestone

Tandem Achieves Cybersecurity Certification Milestone

Tandem Diabetes Care (Nasdaq:TNDM) announced that it achieved ISO/IEC 27001:2022 Certification from Insight Assurance.

The certification affirms Tandem's commitment to cybersecurity, data protection, and operational integrity. It strengthens the company's position in regulated markets as it expands internationally and simplifies compliance for partners and healthcare providers worldwide.

ISO/IEC 27001:2022 is the international benchmark for Information Security Management Systems (ISMS), providing a framework for establishing, implementing, maintaining, and continually improving data security.

ISO/IEC 27001:2022 outlines the essential requirements for an ISMS.

Author's summary: Tandem Diabetes Care achieves ISO certification.

more

Drug Delivery Business Drug Delivery Business — 2025-11-04

More News